Effect of Rhei Radix Et Rhizome on treatment of polycystic ovary syndrome by regulating PI3K/AKT pathway and targeting EGFR/ALB in rats
- 2 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 338 (Pt 1) , 119020
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Traditional Chinese medicine formulae: A complementary method for the treatment of polycystic ovary syndromeJournal of Ethnopharmacology, 2024
- Identification and action mechanism of lipid regulating components from Rhei Radix et rhizomaJournal of Ethnopharmacology, 2022
- Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanismsJournal of Assisted Reproduction and Genetics, 2021
- The pharmacological properties of chrysophanol, the recent advancesBiomedicine & Pharmacotherapy, 2020
- Dose translation between laboratory animals and human in preclinical and clinical phases of drug developmentDrug Development Research, 2018
- Protein Data Bank (PDB): The Single Global Macromolecular Structure Archive2017
- Functional genomics of PCOS: from GWAS to molecular mechanismsTrends in Endocrinology & Metabolism, 2015
- Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic riskFertility and Sterility, 2012
- Ligand docking and binding site analysis with PyMOL and Autodock/VinaJournal of Computer-Aided Molecular Design, 2010
- Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian diseaseArchives of Medical Research, 2004